Legal Opinion
In re New England Compounding Pharmacy, Inc. Products Liability Litigation
District Court, D. Massachusetts
Decided June 12, 2013No. MDL No. 1:13-md-2419-FDSPublishedCited by 14 opinions
1Opinion of the Court
CORRECTED MEMORANDUM AND ORDER ON TRUSTEE’S MOTION TO TRANSFER CASES AND RELATED MOTIONS
F. DENNIS SAYLOR IV, District Judge.
I. Introduction
This litigation involves claims for wrongful death and personal injury arising out of the administration of an injectable steroid, methylprednisolone acetate (“MPA”), manufactured by defendant New England Compounding Pharmacy, Inc. (“NECC”). The complaints allege, in substance, that NECC produced contaminated MPA that led to serious fungal infections and, in some instances, death. As of May 6, 2013, the Centers for Disease Control and Prevention had…
2Cases cited31 opinions
- Connecticut National Bank v. GermainSupreme Court of the United States · 1992
- Stern v. MarshallSupreme Court of the United States · 2011
- In Re Pacor, Inc. v. John Higgins, Jr. And Louise HigginsCourt of Appeals for the Third Circuit · 1984
- Lone Star Fund v (U.S.), L.P. v. Barclays Bank PLCCourt of Appeals for the Fifth Circuit · 2010
- Atlantic Coast Line Railroad v. Brotherhood of Locomotive EngineersSupreme Court of the United States · 1970
26 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- ARK456 Doe v. St. Francis of AssisiDistrict Court, E.D. New York · 2023
- ARK459 Doe v. Franciscan Brothers of BrooklynDistrict Court, E.D. New York · 2023
- ARK663 Doe v. St. John of GodDistrict Court, E.D. New York · 2023
- Doucet v. FCA US LLCDistrict Court, D. Massachusetts · 2020
- Handy v. Box Hill Surgery Ctr., LLC (In re New Eng. Compounding Pharmacy, Inc.)District Court, District of Columbia · 2018
9 more not listed; retrieve them via the Exa API.